CytomX Therapeutics Inc (NASDAQ:CTMX)
| 1.40 BATS BZX Real-Time Price As of 3:53pm ET |  +0.01 / +0.72%Today’s Change | 1.04 Today|||52-Week Range 3.02 | -12.50% Year-to-Date |
Latest CTMX News | Press Releases
Today’s Trading
| Previous close | 1.39 |
| Today’s open | 1.37 |
| Day’s range | 1.37 - 1.42 |
| Volume | 7,025 |
| Average volume (3 months) | 185,369 |
| Market cap | $91.1M |
Data as of 3:53pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -15.91% |
| Earnings growth (this year) | +55.50% |
| Earnings growth (next 5 years) | +0.62% |
| Revenue growth (last year) | -23.59% |
| P/E ratio | NM |
| Price/Sales | 1.98 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DMACDiaMedica Therapeuti... | +0.10 | +4.08% |
| CAPRCapricor Therapeutic... | 0.00 | 0.00% |
| PRPHProphase Labs Inc | -0.03 | -0.59% |
| ETONEton Pharmaceuticals... | +0.07 | +1.98% |
Data as of 3:54pm ET, 12/01/2023
Financials
| Next reporting date | February 28, 2024 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $53.2M |
| Annual profit (last year) | -$99.3M |
| Net profit margin | -186.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
